These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 34111904)

  • 21. Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
    Hessell AJ; Shapiro MB; Powell R; Malherbe DC; McBurney SP; Pandey S; Cheever T; Sutton WF; Kahl C; Park B; Zolla-Pazner S; Haigwood NL
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
    Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA
    J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge.
    Reynolds MR; Weiler AM; Piaskowski SM; Kolar HL; Hessell AJ; Weiker M; Weisgrau KL; León EJ; Rogers WE; Makowsky R; McDermott AB; Boyle R; Wilson NA; Allison DB; Burton DR; Koff WC; Watkins DI
    J Virol; 2010 Sep; 84(18):9190-9. PubMed ID: 20592091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
    Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ
    J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination.
    Kent SJ; Hu SL; Corey L; Morton WR; Greenberg PD
    J Virol; 1996 Aug; 70(8):4941-7. PubMed ID: 8763998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating founder virus information in vaccine field trials.
    Follmann D; Huang CY
    Biometrics; 2015 Jun; 71(2):386-96. PubMed ID: 25773491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of repeated low-dose challenge studies.
    Nolen TL; Hudgens MG; Senb PK; Koch GG
    Stat Med; 2015 May; 34(12):1981-92. PubMed ID: 25752266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.
    Keele BF; Li H; Learn GH; Hraber P; Giorgi EE; Grayson T; Sun C; Chen Y; Yeh WW; Letvin NL; Mascola JR; Nabel GJ; Haynes BF; Bhattacharya T; Perelson AS; Korber BT; Hahn BH; Shaw GM
    J Exp Med; 2009 May; 206(5):1117-34. PubMed ID: 19414559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.
    Schmitz JE; Johnson RP; McClure HM; Manson KH; Wyand MS; Kuroda MJ; Lifton MA; Khunkhun RS; McEvers KJ; Gillis J; Piatak M; Lifson JD; Grosschupff G; Racz P; Tenner-Racz K; Rieber EP; Kuus-Reichel K; Gelman RS; Letvin NL; Montefiori DC; Ruprecht RM; Desrosiers RC; Reimann KA
    J Virol; 2005 Jul; 79(13):8131-41. PubMed ID: 15956558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies.
    O'Connor DH; Allen TM; Watkins DI
    DNA Cell Biol; 2002 Sep; 21(9):659-64. PubMed ID: 12396608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
    Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy.
    Palermo RE; Patterson LJ; Aicher LD; Korth MJ; Robert-Guroff M; Katze MG
    J Virol; 2011 Jan; 85(2):1099-116. PubMed ID: 21068249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of founder viruses in very early SIV rectal transmission.
    Yuan Z; Ma F; Demers AJ; Wang D; Xu J; Lewis MG; Li Q
    Virology; 2017 Feb; 502():97-105. PubMed ID: 28027479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates.
    Warren J
    J Med Primatol; 2002 Aug; 31(4-5):237-56. PubMed ID: 12390546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.